PTC Therapeutics' low P/S ratio is seen as reasonable due to industry underperformance. However, weak revenue outlook is pressuring shares, making maintaining current prices challenging. Shareholders accept the low P/S, expecting no future revenue surprises.
Recent insider selling at PTC Therapeutics outweighs insider buying, a potential bearish sign. Despite some insider buying, the long-term outlook lacks positivity. Insider ownership suggests alignment with shareholders, but insider selling warrants caution.
PTC Therapeutics' ongoing losses may have led to negative market view, causing a contradictory movement in the stock against the company’s revenue growth. The firm's underperformance in the past five years suggests unresolved issues. Currently, the healthcare company has five investment analysis warning signs.
$PTC Therapeutics(PTCT.US)$🚀🚀🚀🚀🚀🚀🚀🔥🔥🔥🔥🔥🔥🔥 Royalty Pharma Announces Agreement to Purchase Up to $1.5 Billion of PTC Therapeutics' Royalty on Evrysdi -- Royalty Pharma purchases a portion of royalties on Roche's Evrysdi for $1.0 billion upfront -- PTC Therapeutics has option to sell rest of royalty for up to $500 million; Royalty Pharma has option to buy half of rest of royalty for up to $250 million -- Transaction expected to enhance long-term Adjusted Cash Receipts growth (non-GAAP) -- R...
*Adobe, Canopy Growth, DoorDash, Nikola* US equities were little changed as of 8:51 a.m. New York time, with Wall Street weighing the latest economic reports ahead of next week’s Federal Reserve decision Here are some of the biggest US movers today: Gainers: 🌟 *Canopy Growth (CGC)* shares jump 20% after the cannabis company ceased funding for BioSteel Sports Nutrition on Thursday 🌟 *Nikola (NKLA)* shares gain 15% putting the electric-vehicle maker on track to extend Thursday...
PTC Therapeutics股票討論區
$1.0 billion upfront
-- PTC Therapeutics has option to sell rest of royalty for up to $500
million; Royalty Pharma has option to buy half of rest of royalty for up
to $250 million
-- Transaction expected to enhance long-term Adjusted Cash Receipts growth
(non-GAAP)
-- R...
Current watch ⚡️
專欄US Premarket Mover
New York time, with Wall Street weighing the latest economic reports ahead of next week’s Federal Reserve decision Here are some of the biggest US movers today: Gainers:
🌟 *Canopy Growth (CGC)* shares jump 20% after the cannabis company ceased funding for BioSteel Sports Nutrition on Thursday
🌟 *Nikola (NKLA)* shares gain 15% putting the electric-vehicle maker on track to extend Thursday...
TOP WATCH AH + 6/23 ⚡️⚡️
TOP WATCH AH + 6/22 ⚡️⚡️
暫無評論